Optimized Cyclophosphamide (CY) Dosing in Combination with Fludarabine, TBI and ATG As Conditioning for Unrelated Donor Bone Marrow Transplantation (BMT) in Severe Aplastic Anemia (SAA): A Phase I/II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)

被引：0
|
作者：
Anderlini, Paolo [1 ]
Wu, Juan [1 ]
Deeg, H. Joachim [1 ]
Gersten, Iris [1 ]
Ewell, Marian [1 ]
Tolar, Jakub [1 ]
Antin, Joseph H. [1 ]
Arai, Sally [1 ]
Horwitz, Mitchell E. [1 ]
McCarty, John M. [1 ]
Nakamura, Ryotaro [1 ]
Pulsipher, Michael A. [1 ]
Adams, Roberta H. [1 ]
Leifer, Eric [1 ]
Carter, Shelly L. [1 ]
DiFronzo, Nancy L. [1 ]
Horowitz, Mary M. [1 ]
Confer, Dennis L. [1 ]
Eapen, Mary [1 ]
机构：
[1] Blood & Marrow Transplant Clin Trials Network, Milwaukee, WI USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 44 条
  • [1] Cyclophosphamide (CY) Conditioning In Patients with Severe Aplastic Anaemia (SAA) Given Unrelated Marrow Transplantation: Final Results of a Phase 1-2 Dose De-Escalation Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0301; NCT 00326417)
    Anderlini, P.
    Wu, J.
    Deeg, H. J.
    Gersten, I.
    Ewell, M.
    Tolar, J.
    Antin, J.
    Arai, S.
    Horwitz, M.
    McCarty, J.
    Nakamura, R.
    Pulsipher, M.
    Adams, R.
    Leifer, E.
    DiFronzo, N.
    Horowitz, M. H.
    Confer, D.
    Eapen, M.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S492 - S493
  • [2] Results of the Blood and Marrow Transplant Clinical Trials Network Study BMT CTN 0601: Scurt - a Multicenter Phase II Trial of Unrelated Donor Reduced Intensity Bone Marrow Transplantation (BMT) for Children with Severe Sickle Cell Disease
    Shenoy, Shalini
    Eapen, Mary
    Wu, Juan
    Walters, Mark C.
    Levine, John E.
    Logan, Brent R.
    Gersten, Iris D.
    Kamani, Naynesh R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S104 - S104
  • [3] High-dose cyclophosphamide (Cy) without bone marrow transplant (BMT) for newly diagnosed or refractory severe aplastic anemia (SAA).
    Brodsky, RA
    Smith, BD
    Chen, A
    Doeblin, TD
    Dorr, D
    Brodsky, I
    Jones, RJ
    BLOOD, 1997, 90 (10) : 1952 - 1952
  • [4] Unrelated Donor Cord Blood Transplantation for Children with Severe Sickle Cell Disease: Results of One Cohort from the Phase II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)
    Kamani, Naynesh R.
    Walters, Mark C.
    Carter, Shelly
    Aquino, Victor
    Brochstein, Joel A.
    Chaudhury, Sonali
    Eapen, Mary
    Freed, Brian M.
    Grimley, Michael
    Levine, John E.
    Logan, Brent
    Moore, Theodore
    Panepinto, Julie
    Parikh, Suhag
    Pulsipher, Michael A.
    Sande, Jane
    Schultz, Kirk R.
    Spellman, Stephen
    Shenoy, Shalini
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (08) : 1265 - 1272
  • [5] A Multicenter Phase II Trial of Unrelated Donor Reduced Intensity Bone Marrow Transplantation for Children with Severe Sickle Cell Disease (SCURT): Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0601) Study
    Shenoy, Shalini
    Eapen, Mary
    Wu, Juan
    Walters, Mark C.
    Levine, John E.
    Logan, Brent
    Gersten, Iris D.
    Kamani, Naynesh R.
    BLOOD, 2015, 126 (23)
  • [6] Excellent results in the treatment of severe aplastic anemia (SAA) using cyclophosphamide (CY) and anti-thymocyte globulin (ATG) as the preparative regimen in allogeneic bone marrow transplantation (BMT).
    Ririe, D
    Shaughnessy, P
    Moore, R
    Ornstein, D
    BLOOD, 1999, 94 (10) : 386B - 386B
  • [7] High-dose cyclophosphamide (Cy) without allogeneic bone marrow transplant (BMT) produces durable complete remissions in severe aplastic anemia (SAA).
    Brodsky, RA
    Smith, BD
    Brodsky, I
    Jones, RJ
    BLOOD, 1999, 94 (10) : 674A - 674A
  • [8] One day busulfan (Bu) and high dose of cyclophosphamide (Cy) as preparative regimen for bone marrow transplantation (BMT) in patients with severe aplastic anemia (SAA).
    Pallotta, RS
    Macedo, MCMA
    Saboya, R
    Dzik, C
    Silva, RL
    Loterio, H
    Massumoto, CM
    Chamone, DAF
    Dulley, FL
    BLOOD, 1997, 90 (10) : 4507 - 4507
  • [9] Non-total body irradiation (TBI) containing preparative regimen in alternative donor bone marrow transplantation (BMT) for severe aplastic anemia (SAA).
    Lee, JH
    Choi, SJ
    Lee, JH
    Lee, YS
    Seol, M
    Lee, JS
    Kim, MW
    Lee, KH
    BLOOD, 2004, 104 (11) : 757A - 757A
  • [10] Addition of antithymocyte globulin (ATG) to cyclophosphamide (Cy) for HLA-identical sibling allogeneic bone marrow transplantation (BMT) for severe aplastic anemia (SAA): Results of a randomized controlled trial.
    Champlin, RE
    Perez, WS
    Passweg, J
    Klein, JP
    Camitta, BM
    Gluckman, E
    Bredeson, C
    Horowitz, MM
    BLOOD, 2003, 102 (11) : 80A - 80A
12345